BioAge Historical Income Statement

BIOA Stock   18.80  0.49  2.54%   
Historical analysis of BioAge Labs, income statement accounts such as Interest Expense of 5.7 M, Selling General Administrative of 9.2 M or Selling And Marketing Expenses of 2.9 M can show how well BioAge Labs, performed in making a profits. Evaluating BioAge Labs, income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of BioAge Labs,'s future profits or losses.
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining BioAge Labs, latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether BioAge Labs, is a good buy for the upcoming year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioAge Labs,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For information on how to trade BioAge Stock refer to our How to Trade BioAge Stock guide.

About BioAge Income Statement Analysis

BioAge Labs, Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to BioAge Labs, shareholders. The income statement also shows BioAge investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

BioAge Labs, Income Statement Chart

At present, BioAge Labs,'s Selling And Marketing Expenses is projected to decrease significantly based on the last few years of reporting. The current year's Other Operating Expenses is expected to grow to about 58.5 M, whereas Depreciation And Amortization is forecasted to decline to about 153.9 K.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of BioAge Labs,. It is also known as BioAge Labs, overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.
Most accounts from BioAge Labs,'s income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into BioAge Labs, current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioAge Labs,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For information on how to trade BioAge Stock refer to our How to Trade BioAge Stock guide.At present, BioAge Labs,'s Selling And Marketing Expenses is projected to decrease significantly based on the last few years of reporting. The current year's Other Operating Expenses is expected to grow to about 58.5 M, whereas Depreciation And Amortization is forecasted to decline to about 153.9 K.
 2023 2024 (projected)
Interest Expense7.8M5.7M
Depreciation And Amortization162K153.9K

BioAge Labs, income statement Correlations

-0.24-0.160.050.070.57-0.49-0.38-0.8-0.19-0.160.4-0.340.33-0.25-0.280.26-0.250.26-0.26
-0.24-0.240.550.62-0.060.060.07-0.110.02-0.39-0.010.090.080.060.41-0.430.44-0.410.43
-0.16-0.24-0.88-0.80.29-0.35-0.320.57-0.370.880.37-0.57-0.54-0.590.58-0.580.65-0.550.58
0.050.55-0.880.94-0.230.280.21-0.540.24-0.94-0.290.40.30.41-0.260.25-0.280.24-0.25
0.070.62-0.80.94-0.220.250.23-0.440.26-0.94-0.240.420.420.43-0.260.24-0.240.24-0.24
0.57-0.060.29-0.23-0.22-0.99-0.95-0.46-0.890.260.98-0.890.19-0.870.09-0.10.07-0.10.1
-0.490.06-0.350.280.25-0.990.970.370.93-0.3-0.990.91-0.180.89-0.090.1-0.090.1-0.1
-0.380.07-0.320.210.23-0.950.970.330.98-0.25-0.970.91-0.10.91-0.080.08-0.070.08-0.08
-0.8-0.110.57-0.54-0.44-0.460.370.330.190.52-0.290.2-0.370.140.27-0.260.32-0.230.26
-0.190.02-0.370.240.26-0.890.930.980.19-0.3-0.940.89-0.040.91-0.140.14-0.130.14-0.14
-0.16-0.390.88-0.94-0.940.26-0.3-0.250.52-0.30.32-0.49-0.45-0.510.49-0.470.45-0.470.47
0.4-0.010.37-0.29-0.240.98-0.99-0.97-0.29-0.940.32-0.90.18-0.890.13-0.130.12-0.140.13
-0.340.09-0.570.40.42-0.890.910.910.20.89-0.49-0.90.261.0-0.420.42-0.40.43-0.42
0.330.08-0.540.30.420.19-0.18-0.1-0.37-0.04-0.450.180.260.28-0.750.75-0.730.75-0.75
-0.250.06-0.590.410.43-0.870.890.910.140.91-0.51-0.891.00.28-0.450.45-0.430.46-0.45
-0.280.410.58-0.26-0.260.09-0.09-0.080.27-0.140.490.13-0.42-0.75-0.45-1.00.95-1.01.0
0.26-0.43-0.580.250.24-0.10.10.08-0.260.14-0.47-0.130.420.750.45-1.0-0.971.0-1.0
-0.250.440.65-0.28-0.240.07-0.09-0.070.32-0.130.450.12-0.4-0.73-0.430.95-0.97-0.940.97
0.26-0.41-0.550.240.24-0.10.10.08-0.230.14-0.47-0.140.430.750.46-1.01.0-0.94-1.0
-0.260.430.58-0.25-0.240.1-0.1-0.080.26-0.140.470.13-0.42-0.75-0.451.0-1.00.97-1.0
Click cells to compare fundamentals

BioAge Labs, Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether BioAge Labs, offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BioAge Labs,'s financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bioage Labs, Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bioage Labs, Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioAge Labs,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For information on how to trade BioAge Stock refer to our How to Trade BioAge Stock guide.
You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BioAge Labs,. If investors know BioAge will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BioAge Labs, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.40)
The market value of BioAge Labs, is measured differently than its book value, which is the value of BioAge that is recorded on the company's balance sheet. Investors also form their own opinion of BioAge Labs,'s value that differs from its market value or its book value, called intrinsic value, which is BioAge Labs,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BioAge Labs,'s market value can be influenced by many factors that don't directly affect BioAge Labs,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BioAge Labs,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if BioAge Labs, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioAge Labs,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.